Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 12, 2008 - Issue 11
Submit an article Journal homepage
401
Views
62
CrossRef citations to date
0
Altmetric
Review

The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets

Francis Rodriguez Bambico McGill University, Neurobiological Psychiatry Unit, Department of Psychiatry, Research and Training Building, 1033 Pine Avenue West, Montréal Québec, H3A 1A1, Canada +1 514 398 1290; +1 514 398 4866; [email protected]
&
Gabriella Gobbi McGill University, Neurobiological Psychiatry Unit, Department of Psychiatry, Research and Training Building, 1033 Pine Avenue West, Montréal Québec, H3A 1A1, Canada +1 514 398 1290; +1 514 398 4866; [email protected]; Université de Montréal, Centre de Recherche Fernand Seguin, Department of Psychiatry, Montreal, Québec, Canada
Pages 1347-1366 | Published online: 14 Oct 2008

Citations (62)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Melissa Slavin, Eliza Barach, Stacey Farmer, Rachel Luba & Mitch Earleywine. (2017) Cannabis and symptoms of PMS and PMDD. Addiction Research & Theory 25:5, pages 383-389.
Read now
Caitlin J. Riebe & Carsten T. Wotjak. (2011) Endocannabinoids and stress. Stress 14:4, pages 384-397.
Read now
Kay Ahn, Douglas S Johnson & Benjamin F Cravatt. (2009) Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders. Expert Opinion on Drug Discovery 4:7, pages 763-784.
Read now

Articles from other publishers (59)

Melissa A. Ribeiro, Rafael P. Aguiar, Franciele F. Scarante, Eduardo J. Fusse, Rúbia M.W. de Oliveira, Francisco S. Guimarães & Alline C. Campos. (2023) The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress. Behavioural Brain Research 450, pages 114502.
Crossref
Kylie O’Brien, Justin Beilby, Michelle Frans, Michael Lynskey, Michael Barnes, Mihindu Jayasuriya, Alkyoni Athanasiou-Fragkouli, Philip Blair & David Nutt. (2023) Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life. Drug Science, Policy and Law 9, pages 205032452311725.
Crossref
Wahid Zada, Jonathan W. VanRyzin, Miguel Perez‐Pouchoulen, Samantha L. Baglot, Matthew N. Hill, Ghulam Abbas, Sarah M. Clark, Umer Rashid, Margaret M. McCarthy & Abdul Mannan. (2022) Fatty acid amide hydrolase inhibition and N‐arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants. Pharmacology Research & Perspectives 10:5.
Crossref
Michał Graczyk, Agata Anna Lewandowska, Piotr Melnyczok, Adam Zgliński & Małgorzata Łukowicz. (2022) Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series. Biomedicines 10:8, pages 1862.
Crossref
AmirMohammad Sharafi, Sina Pakkhesal, Ali Fakhari, Nazli Khajehnasiri & Ali Ahmadalipour. (2022) Rapid treatments for depression: Endocannabinoid system as a therapeutic target. Neuroscience & Biobehavioral Reviews 137, pages 104635.
Crossref
Tarapati Rana, Tapan Behl, Aayush Sehgal, Vineet Mehta, Sukhbir Singh, Ravinder Kumar & Simona Bungau. (2021) Integrating Endocannabinoid Signalling In Depression. Journal of Molecular Neuroscience 71:10, pages 2022-2034.
Crossref
Shannon C Waye, O Chandani Dinesh, SM Nageeb Hasan, Joshua D Conway, Roger Raymond, José N Nobrega, Jacqueline Blundell & Francis Rodriguez Bambico. (2021) Antidepressant action of transcranial direct current stimulation in olfactory bulbectomised adolescent rats. Journal of Psychopharmacology 35:8, pages 1003-1016.
Crossref
Salar Vaseghi, Shirin Arjmandi-Rad, Mohammad Nasehi & Mohammad-Reza Zarrindast. (2021) Cannabinoids and sleep-wake cycle: The potential role of serotonin. Behavioural Brain Research 412, pages 113440.
Crossref
Srinagesh Mannekote Thippaiah, Sloka S. Iyengar & K. Yaragudri Vinod. (2021) Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors. Frontiers in Psychiatry 12.
Crossref
Michał Graczyk, Małgorzata Łukowicz & Tomasz Dzierzanowski. (2021) Prospects for the Use of Cannabinoids in Psychiatric Disorders. Frontiers in Psychiatry 12.
Crossref
Rafael M. Bitencourt, Reinaldo N. Takahashi & Elisaldo A. Carlini. (2021) From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?. Frontiers in Psychiatry 12.
Crossref
Xiao-Lie He, Li Yang, Zhao-Jie Wang, Rui-Qi Huang, Rong-Rong Zhu & Li-Ming Cheng. (2021) Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder. Neural Regeneration Research 16:3, pages 537.
Crossref
Samia Joca, Gabriela P. Silote, Ariandra Sartim, Amanda Sales, Francisco Guimarães & Gregers Wegener. 2021. The Neuroscience of Depression. The Neuroscience of Depression 459 467 .
Mohaddeseh Ebrahimi-Ghiri & Fatemeh Khakpai. 2021. The Neuroscience of Depression. The Neuroscience of Depression 293 300 .
Kylie O'Brien & Philip BlairKylie O’Brien & Philip Blair. 2021. Medicinal Cannabis and CBD in Mental Healthcare. Medicinal Cannabis and CBD in Mental Healthcare 195 252 .
Julien Elowe, Philippe Golay, Philipp S. Baumann, Alessandra Solida-Tozzi & Philippe Conus. (2020) Moderating role of cannabis use between insight and depression in early psychosis. Schizophrenia Research 215, pages 61-65.
Crossref
Gabriela Pandini Silote, Ariandra Sartim, Amanda Sales, Amanda Eskelund, F.S. Guimarães, Gregers Wegener & Samia Joca. (2019) Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. Journal of Chemical Neuroanatomy 98, pages 104-116.
Crossref
Mohaddeseh Ebrahimi-Ghiri, Mohammad Nasehi & Mohammad-Reza Zarrindast. (2019) Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment. Behavioural Brain Research 364, pages 296-302.
Crossref
An-qi Yin, Feng Wang & Xia Zhang. (2018) Integrating endocannabinoid signaling in the regulation of anxiety and depression. Acta Pharmacologica Sinica 40:3, pages 336-341.
Crossref
Amber L. Bahorik, Stacy A. Sterling, Cynthia I. Campbell, Constance Weisner, Danielle Ramo & Derek D. Satre. (2018) Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. Journal of Affective Disorders 241, pages 8-14.
Crossref
Bruna Cuccurazzu, Erica Zamberletti, Cristiano Nazzaro, Pamela Prini, Massimo Trusel, Mariagrazia Grilli, Daniela Parolaro, Raffaella Tonini & Tiziana Rubino. (2018) Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling. International Journal of Neuropsychopharmacology 21:11, pages 1014-1024.
Crossref
Jana Tchekalarova, Keylla da Conceição Machado, Antonio Luiz Gomes Júnior, Ana Amélia de Carvalho Melo Cavalcante, Albena Momchilova & Rumyana Tzoneva. (2018) Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice. Seizure 57, pages 22-26.
Crossref
Claudio D'Addario, Vincenzo Micale, Martina Di Bartolomeo, Tibor Stark, Mariangela Pucci, Alexandra Sulcova, Mariacarlotta Palazzo, Zuzana Babinska, Laura Cremaschi, Filippo Drago, A. Carlo Altamura, Mauro Maccarrone & Bernardo Dell'Osso. (2017) A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia. Schizophrenia Research 188, pages 132-140.
Crossref
Erica Zamberletti, Fabiana Piscitelli, Valentina De Castro, Elisabetta Murru, Marina Gabaglio, Paola Colucci, Chiara Fanali, Pamela Prini, Tiziana Bisogno, Mauro Maccarrone, Patrizia Campolongo, Sebastiano Banni, Tiziana Rubino & Daniela Parolaro. (2017) Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via changes in brain endocannabinoid system. Journal of Lipid Research 58:2, pages 301-316.
Crossref
Eva M Marco, Javier Antonio Ballesta, Carlos Irala, María-Donina Hernández, María Elisa Serrano, Virginia Mela, Meritxell López-Gallardo & María-Paz Viveros. (2017) Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences. Pharmacology Biochemistry and Behavior 152, pages 68-80.
Crossref
Tristram A. Lett, Henrik Walter & Eva J. Brandl. (2016) Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies. CNS Drugs 30:12, pages 1169-1189.
Crossref
Carla Gonzales-Arimborgo, Irma Yupanqui, Elsa Montero, Dulce Alarcón-Yaquetto, Alisson Zevallos-Concha, Lidia Caballero, Manuel Gasco, Jianping Zhao, Ikhlas Khan & Gustavo Gonzales. (2016) Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study. Pharmaceuticals 9:3, pages 49.
Crossref
Gabriella Gobbi, Nicolas Nu?ez, Ryan McLaughin & Francis Bambico. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse 815 826 .
Farzaneh Najar, Mohammad Nasehi, Seyed-Ali Haeri-Rohani & Mohammad-Reza Zarrindast. (2015) The involvement of medial septum 5-HT 1 and 5-HT 2 receptors on ACPA-induced memory consolidation deficit: Possible role of TRPC3, TRPC6 and TRPV2 . Journal of Psychopharmacology 29:11, pages 1200-1208.
Crossref
Lindsay Silva, Lauren Harte-Hargrove, Sari Izenwasser, Ashley Frank, Dean Wade & Diana Dow-Edwards. (2015) Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat. Neuroscience Letters 602, pages 89-94.
Crossref
Eric P. Baron. (2015) Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. Headache: The Journal of Head and Face Pain 55:6, pages 885-916.
Crossref
Abhishek Ghosh & Debasish Basu. (2015) Cannabis and psychopathology: The meandering journey of the last decade. Indian Journal of Psychiatry 57:2, pages 140.
Crossref
Zhen Zhang, Wei Wang, Peng Zhong, Sarah J. Liu, Jonathan Z. Long, Li Zhao, Hai-qing Gao, Benjamin F. Cravatt & Qing-song Liu. (2015) Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. Hippocampus 25:1, pages 16-26.
Crossref
R T Miller, S Miksys, E Hoffmann & R F Tyndale. (2014) Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys. British Journal of Pharmacology 171:12, pages 3077-3088.
Crossref
Oualid Abboussi, Abdelouahhab Tazi, Eleni Paizanis & Soumaya El Ganouni. (2014) Chronic exposure to WIN55,212-2 affects more potently spatial learning and memory in adolescents than in adult rats via a negative action on dorsal hippocampal neurogenesis. Pharmacology Biochemistry and Behavior 120, pages 95-102.
Crossref
Ian Mahar, Francis Rodriguez Bambico, Naguib Mechawar & José N. Nobrega. (2014) Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neuroscience & Biobehavioral Reviews 38, pages 173-192.
Crossref
Matthew N Hill & Sachin Patel. (2013) Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses. Biology of Mood & Anxiety Disorders 3:1, pages 19.
Crossref
Gabriella Gobbi. 2013. Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders. Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders 255 275 .
Francis Rodriguez Bambico, Patrick R. Hattan, Jean-Philippe Garant & Gabriella Gobbi. (2012) Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission. Progress in Neuro-Psychopharmacology and Biological Psychiatry 38:1, pages 88-96.
Crossref
Susana Esteban & Jes?s A. Garc?a-Sevilla. (2012) Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 38:1, pages 78-87.
Crossref
Sergio Domínguez-López, Ian Mahar, Francis Rodriguez Bambico, Benoit Labonté, Rafael Ochoa-Sánchez, Marco Leyton & Gabriella Gobbi. (2011) Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light–dark cycle. Journal of Psychopharmacology 26:6, pages 830-844.
Crossref
Francis Rodriguez Bambico & Catherine Belzung. 2013. Neurogenesis and Neural Plasticity. Neurogenesis and Neural Plasticity 243 291 .
Louisa Degenhardt, Wayne Hall, Michael Lynskey, Carolyn Coffey & George Patton. 2011. Marijuana and Madness. Marijuana and Madness 114 128 .
Cecilio Lopez-Munoz & Francisco AlamoRyan McLaughlin, Francis Bambico & Gabriella Gobbi. 2011. Neurobiology of Depression. Neurobiology of Depression 203 222 .
Jonathan Z. Long, Melanie LaCava, Xin Jin & Benjamin F. Cravatt. (2011) An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. Journal of Lipid Research 52:2, pages 337-344.
Crossref
Francis Rodriguez Bambico, Tommaso Cassano, Sergio Dominguez-Lopez, Noam Katz, Claire Dominique Walker, Daniele Piomelli & Gabriella Gobbi. (2010) Genetic Deletion of Fatty Acid Amide Hydrolase Alters Emotional Behavior and Serotonergic Transmission in the Dorsal Raphe, Prefrontal Cortex, and Hippocampus. Neuropsychopharmacology 35:10, pages 2083-2100.
Crossref
Marcel Jenny, Sebastian Schröcksnadel, Florian Überall & Dietmar Fuchs. (2010) The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism. Pharmaceuticals 3:8, pages 2647-2660.
Crossref
MS García‐Gutiérrez, JM Pérez‐Ortiz, A Gutiérrez‐Adán & J Manzanares. (2010) Depression‐resistant endophenotype in mice overexpressing cannabinoid CB 2 receptors . British Journal of Pharmacology 160:7, pages 1773-1784.
Crossref
Chad E. Beyer, Jason M. Dwyer, Michael J. Piesla, Brian J. Platt, Ru Shen, Zia Rahman, Karen Chan, Melissa T. Manners, Tarek A. Samad, Jeffrey D. Kennedy, Brendan Bingham & Garth T. Whiteside. (2010) Depression-like phenotype following chronic CB1 receptor antagonism. Neurobiology of Disease 39:2, pages 148-155.
Crossref
David P. Finn. (2010) Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance. Immunobiology 215:8, pages 629-646.
Crossref
Valentina Onnis, Cenzo Congiu, Emmelie Björklund, Franziska Hempel, Emma Söderström & Christopher J. Fowler. (2010) Synthesis and Evaluation of Paracetamol Esters As Novel Fatty Acid Amide Hydrolase Inhibitors. Journal of Medicinal Chemistry 53:5, pages 2286-2298.
Crossref
Francis Rodriguez Bambico, Nhu-Tram Nguyen, Noam Katz & Gabriella Gobbi. (2010) Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiology of Disease 37:3, pages 641-655.
Crossref
John Kelly. 2010. Principles of CNS Drug Development. Principles of CNS Drug Development 245 286 .
Brian D. Hudson, Terence E. Hébert & Melanie E. M. Kelly. (2010) Ligand- and Heterodimer-Directed Signaling of the CB 1 Cannabinoid Receptor . Molecular Pharmacology 77:1, pages 1-9.
Crossref
Anna C. Morrish, Matthew N. Hill, Caitlin J.N. Riebe & Boris B. Gorzalka. (2009) Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: Role of gender and noradrenergic transmission. Physiology & Behavior 98:1-2, pages 118-124.
Crossref
Fabrício A. Moreira & José Alexandre S. Crippa. (2009) The psychiatric side-effects of rimonabant. Revista Brasileira de Psiquiatria 31:2, pages 145-153.
Crossref
Francis Rodriguez Bambico, Nhu-Tram Nguyen & Gabriella Gobbi. (2009) Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. European Neuropsychopharmacology 19:3, pages 215-228.
Crossref
Beat Lutz. (2009) Endocannabinoid signals in the control of emotion. Current Opinion in Pharmacology 9:1, pages 46-52.
Crossref
Jeffrey M. Witkin & Xia Li. 2009. Contemporary Aspects of Biomedical Research - Drug Discovery. Contemporary Aspects of Biomedical Research - Drug Discovery 347 379 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.